Ganirelix is a synthetic gonadotropin-releasing hormone (GnRH) antagonist, primarily used in assisted reproductive technology (ART) for ovarian stimulation cycles.By competitively blocking pituitary GnRH receptors, it rapidly suppresses luteinizing hormone (LH) release, effectively preventing premature ovulation.Ganirelix is characterized by its rapid onset and short duration of action, allowing precise control of ovulation induction and improving oocyte retrieval efficiency. It is a key medication in in vitro fertilization (IVF) treatment.
Product Overview
Basic Description |
Structure and Function:
In Vitro and In Vivo Studies:
|
Complete sequence |
Pyr-His-Trp-Ser-Tyr-D-Phe-Leu-Arg-Pro-Gly-NH2 |
Simplify sequence |
PHWSTYDPLRPG |
CAS |
123246-29-7 |
Molecular formula |
C58H74N16O10 |
Molecular weight |
1184.3 g/mol |
Product Attributes
purity |
>98% |
form |
Lyophilized powder |
Storage conditions |
Store at -20°C in a cool, dry place |